Contact Us
Drug Search Results
More Filters [+]

Vinpocetine

Alternative Names: vinpocetine, vinpocetin
Latest Update: 2024-10-10
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: PDE Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral,Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Bangladesh | Bosnia | Bulgaria | China | Czech | Dominican Republic | Ecuador | Egypt | Hungary | India | Latvia | Lithuania | Mexico | Pakistan | Peru | Poland | Portugal | Romania | Russia | Serbia | Singapore | Slovakia | Slovenia | Spain | Ukraine | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Amen Clinics
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Vinpocetine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Inflammation|Kidney Diseases|Diabetic Nephropathy|Stroke

Phase 2: Epilepsy

Phase 1: Fetal Alcohol Spectrum Disorders

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
IRB00044949

P2

Suspended

Epilepsy

2026-12-01

Protocol: 77615

P1

Not yet recruiting

Fetal Alcohol Spectrum Disorders

2026-06-01

NCT06441591

P3

Recruiting

Kidney Diseases|Diabetic Nephropathy

2025-06-01

ChiCTR-IOR-14005688

N/A

Not yet recruiting

Unknown

2018-12-31

Recent News Events

Date

Type

Title

07/23/2024

News Article

 Global Cardiovascular Health Supplements Market worth $16.06 billion by 2030, Exclusive Report by Coherent Market Insights

07/22/2024

News Article

 Dyslexia Treatment Market Size to hit $11.74 billion by 2031, growing at a CAGR of 6.4%, says Coherent Market Insights

07/09/2024

News Article

 Global Workout Supplements Market Size to worth $36.38 billion by 2030, growing at a CAGR of 10.9%, says Coherent Market Insights

06/03/2024

News Article

 Nika Pharmaceuticals, Inc. (NIKA) Presents Its Business Strategy

05/13/2024

PubMed

 The ameliorative effect of vinpocetine against gentamicin-induced uterine-injury in rats involves the inflammasome/caspase-1/IL-1beta pathway.

05/11/2024

PubMed

 Regulation of cerebral blood flow boosts precise brain targeting of vinpocetine-derived ionizable-lipidoid nanoparticles.

04/09/2024

PubMed

 Symptomatic Cavum Vergae Cyst in a Geriatric Patient: A Report of a Rare Case and Conservative Management Approach.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions